KKR Forms Falcon Vision to Advance Innovation in Ophthalmology
February 26, 2019
New Platform to Manage Portfolio of Emerging Ophthalmology Assets
in Collaboration with
Falcon Vision will collaborate with the team at
“Ophthalmology is an important and attractive area for innovation given
the unmet need across multiple disease categories, an aging population
and the quality-of-life consequences of vision loss,” said
“There is a significant opportunity to accelerate much-needed therapies
in the ophthalmic sector with flexible capital and operational
guidance,” said
For KKR, the investment is from its
About KKR
KKR is a leading global investment firm that manages multiple
alternative asset classes, including private equity, energy,
infrastructure, real estate and credit, with strategic partners that
manage hedge funds. KKR aims to generate attractive investment returns
for its fund investors by following a patient and disciplined investment
approach, employing world-class people, and driving growth and value
creation with KKR portfolio companies. KKR invests its own capital
alongside the capital it manages for fund investors and provides
financing solutions and investment opportunities through its capital
markets business. References to KKR’s investments may include the
activities of its sponsored funds. For additional information about
About Falcon Vision
Falcon Vision is an ophthalmology-focused platform supported by KKR. The
platform will invest in and manage a diversified portfolio of emerging
assets across medical devices and biopharmaceuticals. Falcon Vision’s
strategy is to address the need for capital, access to executive talent,
and operational guidance to support advancement of innovative products
for under-managed ophthalmic diseases and vision preservation. Falcon
Vision will collaborate with the team at
About
Flying L Partners brings together business and clinical leaders with
decades-long track records of building, leading, and funding high-impact
ophthalmic technologies. The mission is to identify promising
opportunities and accelerate value creation with strategic and
operational insights. Flying L Partners focuses on both medical device
and biopharmaceutical opportunities with differentiated clinical value
propositions, identified regulatory and reimbursement paths, and
tangible milestones to crystalize value. The team at
View source version on businesswire.com: https://www.businesswire.com/news/home/20190226005352/en/
Tel: + 1 (212) 750-8300
media@kkr.com
Source: KKR
Back to Press Releases
Media Contacts
Americas
Miles Radcliffe-Trenner
Telephone: +1 (212) 750-8300
Email: media@kkr.com
Investor Relations
Craig Larson
Telephone: +1 (877) 610-4910
Outside US: +1 (212) 230-9410
Facsimile: +1 (212) 750-0003
Email: Investor-Relations@kkr.com